iRhythm Technologies Inc (IRTC, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. iRhythm Technologies Inc has a market cap of $2.35 billion; its shares were traded at around $97.34 with and P/S ratio of 17.38.
For the last quarter iRhythm Technologies Inc reported a revenue of $43.2 million, compared with the revenue of $28.18 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $147.3 million, an increase of 49.5% from last year.
The reported loss per diluted share was $2.02 for the year, compared with the loss per share of $1.57 in the previous year. The iRhythm Technologies Inc had an operating margin of -29.61%, compared with the operating margin of -27.68% a year before. The 10-year historical median operating margin of iRhythm Technologies Inc is -43.77%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, iRhythm Technologies Inc has the cash and cash equivalents of $20.0 million, compared with $8.67 million in the previous year. The long term debt was $34.9 million, compared with $32.5 million in the previous year. iRhythm Technologies Inc has a financial strength rank of 6 (out of 10).
At the current stock price of $97.34, iRhythm Technologies Inc is traded at 34% premium to its historical median P/S valuation band of $72.64. The P/S ratio of the stock is 17.38, while the historical median P/S ratio is 12.98. The stock gained 56.39% during the past 12 months.
CFO Recent Trades:
- CFO Matthew C. Garrett sold 20,203 shares of IRTC stock on 02/13/2019 at the average price of $90.1. The price of the stock has increased by 8.04% since.
Directors and Officers Recent Trades:
- EVP, Sales David A Vort sold 5,044 shares of IRTC stock on 02/25/2019 at the average price of $94.85. The price of the stock has increased by 2.63% since.
- Director Bruce G. Bodaken sold 2,158 shares of IRTC stock on 02/25/2019 at the average price of $95.9. The price of the stock has increased by 1.5% since.
- EVP, Sales David A Vort sold 758 shares of IRTC stock on 02/22/2019 at the average price of $95. The price of the stock has increased by 2.46% since.
- EVP, Sales David A Vort sold 4,286 shares of IRTC stock on 02/19/2019 at the average price of $92.66. The price of the stock has increased by 5.05% since.
- EVP, Sales David A Vort sold 5,044 shares of IRTC stock on 02/13/2019 at the average price of $90.84. The price of the stock has increased by 7.16% since.
For the complete 20-year historical financial data of IRTC, click here.
